Skip Navigation
Search Menu
Find a Doctor

 

Photo of Dr. Lauren Jansson

Lauren Melissa Jansson, M.D.

Director of Pediatrics, Center for Addiction and Pregnancy
Associate Professor of Pediatrics

Female

Appointment Phone

410-550-3033

Main Location

Johns Hopkins Bayview Medical Center

Out-of-State & International Patients +
Out of State Patients

Call 410-464-6641 (8a.m. to 6p.m., EST, Mon-Fri)

Learn more about our out-of-state patient services »

International Patients

Call +1-410-502-7683 (7a.m. to 6p.m., EST, Mon-Fri)

Learn more about our international patient services »

Titles

  • Director of Pediatrics, Center for Addiction and Pregnancy
  • Associate Professor of Pediatrics

Centers & Institutes

Departments

  • Pediatrics - General Pediatrics and Adolescent Medicine

Locations

Johns Hopkins Bayview Medical Center

Appointment Phone: 410-550-3033

4940 Eastern Avenue
The Center for Addiction and Pregnancy
Baltimore, MD 21224 map
Phone: 410-550-5438
Fax: 410-550-2713

Johns Hopkins Bayview Medical Center

GI Clinic
4940 Eastern Avenue
A Building, 5th floor
Baltimore, MD 21224 map

Johns Hopkins Bayview Medical Center

4940 Eastern Avenue
Oculoplastics, Room A623
Baltimore, MD 21224 map

Expertise

Drug Abuse Research, Drug Exposed Infants and Children, Pediatrics

Research Interests

Fetal neurobehavioral development in drug exposed pregnancies

Biography

Dr. Lauren Melissa Jansson is an associate professor of pediatrics at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include drug abuse research, drug-exposed infants and children, and pediatrics.

Since 1991, Dr. Jansson has been the director of pediatrics at the Center for Addiction and Pregnancy, a comprehensive care treatment facility for pregnant and parenting drug-dependent women and their children.

Dr. Jansson earned her M.D. from the State University of New York at Downstate Medical Center. She completed her residency at the Children’s Hospital at Albany Medical Center and performed a fellowship in developmental and behavioral pediatrics at the Albert Einstein College of Medicine.

Her research interests include fetal neurobehavioral development in drug-exposed pregnancies, lactation in opioid-dependent women on medication assisted treatment, and neonatal abstinence syndrome resulting from in utero opiate and other substance exposures.

Dr. Jansson is a member of several professional organizations, including the College on Problems of Drug Dependence, the Academic Pediatric Association, and the Society for Pediatric Research.

...read more

    Additional Information

  • Education +

    Degrees

    • State University New York Albany / BS; Biology (1981)
    • SUNY at Brooklyn College of Medicine / MD; Medicine (1985)

    Residencies

    • Albany Medical College / Pediatrics (1988)

    Fellowships

    • Albert Einstein College of Medicine of Yeshiva University / Developmental and Behavioral Pediatrics (1990)

    Certifications

    • American Board of Pediatrics / Pediatrics - General (1989, 2016)
  • Research & Publications +

    Research Summary

    Dr. Jansson's research involves the fetuses, infants and children of drug-dependent mothers. She is the principal investigator of a NIDA-funded project that involves the evaluation of fetal and infant neurobehaviors after prenatal exposure to buprenorphine and other illicit and licit substances. The research seeks to determine the pathogenesis of neonatal abstinence syndrome—the constellation of signs and symptoms of withdrawal after birth in prenatally opioid exposed infants—in this group.

    Other projects include the evaluation of concentrations of buprenorphine and its metabolite in infant plasma, and breast milk and plasma of lactating women; fetal neurobehaviors in methadone- versus buprenorphine-exposed pregnancies; the effects of fetal gender on infant outcomes; and the effects of polysubstance use on fetal and infant neurobehaviors.

    Dr. Jansson's research has the overarching goal of optimizing evaluation and treatment for the vulnerable population of drug-dependent pregnant and postpartum women and their infants and children.

    Clinical Trial Keywords: drug exposed infant, neonatal abstinence syndrome, drug abuse in pregnancy, fetus, methadone

    Selected Publications

    Agthe AG, Kim GR, Mathias KB, Hendrix CW, Chavez-Valdez R, Jansson L, Lewis TR, Yaster M, Gauda EB. "Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial." Pediatrics. 2009 May;123(5):e849-56. doi: 10.1542/peds.2008-0978. Epub 2009 Apr 27.

    Jansson LM, Velez M, Harrow C. "The opioid-exposed newborn: assessment and pharmacologic management." J Opioid Manag. 2009 Jan-Feb;5(1):47-55. Review.

    Jansson LM, Dipietro JA, Velez M, Elko A, Knauer H, Kivlighan KT. "Maternal methadone dosing schedule and fetal neurobehaviour." J Matern Fetal Neonatal Med. 2009 Jan;22(1):29-35. doi: 10.1080/14767050802452291.

    Velez M, Jansson LM. "The Opioid dependent mother and newborn dyad: non-pharmacologic care." J Addict Med. 2008 Sep;2(3):113-20. doi: 10.1097/ADM.0b013e31817e6105.

    Jansson LM, Choo R, Velez ML, Lowe R, Huestis MA. "Methadone maintenance and long-term lactation." Breastfeed Med. 2008 Mar;3(1):34-7. doi: 10.1089/bfm.2007.0032.

    Jansson LM, Choo R, Velez ML, Harrow C, Schroeder JR, Shakleya DM, Huestis MA. "Methadone maintenance and breastfeeding in the neonatal period." Pediatrics 2008;121(1):106-114.

    Choo RE, Jansson LM, Scheidweiler K, Huestis MA. "A validated liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometric method for the quantification of methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), and 2-ethly-5-methyl-3,3-diphenylpyroline (EDMP) in human breast milk." Journal of Analytic Toxicology 2007;31:265-269.

    Shakleya DM, Jansson LM, Huestis MA. "Validation of a LC-APCI-MS/MS Method for the Quantification of Methadone, 2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) and 2-Ethyl-5-methyl-3,3-diphenylpyraline (EMDP) in Infant Plasma Following Protein Precipitation." Journal of Chromatography B 2007;856:267-272.

    Jansson LM, DiPietro JA, Elko A, Velez M. "Maternal vagal tone change in response to methadone is associated with neonatal abstinence syndrome severity in exposed neonates." J of Maternal, Fetal and Neonatal Medicine 2007;20(9):677-685.

    Crocetti MT, Amin DD, Jansson LM. "Variability in the Evaluation and Management of Opiate-Exposed Newborns in Maryland." Clinical Pediatrics 2007;46(7)632-635.

    Jansson LM, Choo RE, Harrow C, Velez M, Schroeder JR, Lowe R, Huestis M. "Concentrations of Methadone in Breast Milk and Plasma in the Immediate Perinatal Period." Journal of Human Lactation 2007;23(2):184-190.

    Jansson LM, Svikis DS, Velez M, Fitzgerald E, Jones HE. "The Impact of Managed Care on Drug Dependent Pregnant and Postpartum Women and their Children." Substance Use and Misuse 2007;42:1-14.

    Velez ML, Montoya ID, Jansson LM, Walters V, Svikis D, Jones HE, Chilcoat H, Campbell JC. "Exposure to Violence among Substance-Dependent Pregnant Women and their Children." Journal of Substance Abuse Treatment 2006;30:31-38.

    Miles D, Lanni S, Jansson L, Svikis D. "Smoking and Illicit Drug Use during Pregnancy: Impact on Neonatal Outcome." Journal of Reproductive Medicine 2006;51(7):567-572.

    Jansson LM, Elko A, DiPietro J. "Fetal Response to Maternal Methadone Administration." American Journal of Obstetrics and Gynecology 2005;193(3):611-617.

    Jones HE, Johnson RE, Jasinski DR, OGrady KE, Chisolm CA, Choo RE, Crocetti M, Dudas R, Harrow C, Huestis MA, Jansson LM, et al. "Buprenorphine versus Methadone in the Treatment of Pregnant Opioid-Dependent Patients: Effects on the Neonatal Abstinence Syndrome." Drug and Alcohol Dependence 2005;79(1):110.

    Jansson LM, Svikis DS, Breon D, Cieslak R. "Intensity of Case Management Services: Does More = Better for Drug-Dependent Women and their Children?" Social Work in Mental Health 2004;3(4):63-78.

    Velez M, Jansson LM, Montoya I, Schweitzer W, Golden A, Svikis DS. "Parenting Knowledge among Substance Abusing Women in Treatment." Journal of Substance Abuse Treatment 2004;27:215-222.

    Jansson LM, Velez ML, Harrow C. "Methadone Maintenance and Lactation: A Review of the Literature and Current Management Guidelines." Journal of Human Lactation 2004; 20(1):62-71.

    Jansson LM, Svikis DS, Beilenson P. "Effectiveness of Child Case Management Services for Offspring of Drug Dependent Women." Substance Use and Misuse 2003;38(14):1933-1952.

    Johnson RE, Jones HE, Jasinski DR, Svikis DS, Haug NA, Jansson LM, et al. "Buprenorphine Treatment of Opioid-Dependent Women: Maternal and Neonatal Outcomes." Drug and Alcohol Dependence 2001;63:97-103.

    Jansson LM, Velez M. "Understanding and Treating Substance Abusers and Their Infants." Infants and Young Children 1999;1(4):79-89.

    Jansson LM, Svikis D, Lee J, Paluzzi P, Rutigliano P, Hackerman F. "Pregnancy and Addiction: A Comprehensive Care Model." Journal of Substance Abuse Treatment 1996;13(4): 321-329.

  • Academic Affiliations & Courses +
  • Activities & Honors +

    Honors

    • Best Immunization Practices Award, Maryland Bureau of Child Health and Immunization, 2005 - 2009
    • Child Health Promotion Award, Maryland Childhood Immunization Partnership, 2005

    Memberships

    • Academic Pediatric Association
      Member
    • College on Problems of Drug Dependence
      Member
    • Society for Pediatric Research
      Member
  • Videos & Media +
Is This You? Edit Profile